Newsroom
Your source for Evernorth news.
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible
New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patients
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (52)
Press Release
Express Scripts Sues FTC, Demands Withdrawal of PBM Report
September 17, 2024
Press Release
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early May
September 05, 2024
Press Release
Evernorth Names Tony Colistra New President of MD Live, Evernorth Workplace Care
September 04, 2024
Press Release
Express Scripts by Evernorth Members Paid Less for Their Share of Prescriptions in 2023 Despite Drug Price Increases
June 19, 2024
Members with employer-sponsored insurance saw about a 1% decrease in their portion out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply
Press Release
Express Scripts enhances strategies to support access to care at independent pharmacies
May 23, 2024
Based on guidance from its Independent Pharmacy Advisory Committee, Express Scripts will collaborate with CPESN ® USA through its IndependentRx initiative.
Press Release
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
April 25, 2024